Drugs and lotions, Marketing

FDA Urged to Look More Closely at Beauty Products

An editorial published in JAMA Internal Medicine urges better surveillance of cosmetic products. Consumers can already report adverse effects to the FDA’s CFSAN Adverse Event Reporting System (CAERS), but it was only in Dec 2016 that the FDA began to make this information publicly available.  Hair care products, skin care products and tattoos were most commonly reported as the source of problems, according to Steve Xu, a resident physician in dermatology at the McGaw Medical Center of Northwestern University and author of a study on problems with personal care products.